These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16529176)

  • 21. Evaluation of monolithic and sub 2 microm particle packed columns for the rapid screening for illicit drugs--application to the determination of drug contamination on Irish euro banknotes.
    Bones J; Macka M; Paull B
    Analyst; 2007 Mar; 132(3):208-17. PubMed ID: 17325753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.
    Musshoff F; Madea B
    Ther Drug Monit; 2006 Apr; 28(2):155-63. PubMed ID: 16628124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
    Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
    J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The recovery of illicit drugs from oral fluid sampling devices.
    Dickson S; Park A; Nolan S; Kenworthy S; Nicholson C; Midgley J; Pinfold R; Hampton S
    Forensic Sci Int; 2007 Jan; 165(1):78-84. PubMed ID: 16621382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.
    Michna E; Jamison RN; Pham LD; Ross EL; Janfaza D; Nedeljkovic SS; Narang S; Palombi D; Wasan AD
    Clin J Pain; 2007 Feb; 23(2):173-9. PubMed ID: 17237667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control.
    Parr MK; Fusshöller G; Schlörer N; Opfermann G; Piper T; Rodchenkov G; Schänzer W
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):207-18. PubMed ID: 19089863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug addiction in the medico-legal certification of the Department of Forensic Medicine of Medical University of Gdańsk in the years 1996-2005].
    Galer-Tatarowicz K; Wiergowski M; Szpiech B; Reguła K; Jankowski Z
    Arch Med Sadowej Kryminol; 2007; 57(3):277-84. PubMed ID: 17907619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use?
    Manchikanti L; Pampati V; Damron KS; McManus CD
    Pain Physician; 2004 Jan; 7(1):71-5. PubMed ID: 16868615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confirmatory analysis of Trenbolone using accurate mass measurement with LC/TOF-MS.
    Blokland MH; Zoontjes PW; Sterk SS; Stephany RW; Zweigenbaum J; van Ginkel LA
    Anal Chim Acta; 2008 Jun; 618(1):86-93. PubMed ID: 18501249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of rapid tests in drug substitution].
    Scholer A
    Praxis (Bern 1994); 2002 Sep; 91(37):1465-6. PubMed ID: 12360681
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques.
    Moal V; Mathieu E; Reynier P; Malthièry Y; Gallois Y
    Clin Chim Acta; 2007; 386(1-2):12-9. PubMed ID: 17706625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice.
    Fox EJ; Twigger S; Allen KR
    Ann Clin Biochem; 2009 Jan; 46(Pt 1):50-7. PubMed ID: 19103958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical considerations in the interpretation of urine drug screens.
    Summer GL
    Ala Med; 1992 Dec; 62(6):23-5. PubMed ID: 1292334
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing.
    Jaffee WB; Trucco E; Levy S; Weiss RD
    J Subst Abuse Treat; 2007 Jul; 33(1):33-42. PubMed ID: 17588487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.